Tyra Biosciences, Inc.
HealthcareNASDAQ:TYRA · NASDAQ Global Select
+$1.42 today
Vol 1.01M · Avg 0.96M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+158.77%
Period High
$39.61
Period Low
$9.10
Latest
$26.99
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Nanobiotix S.A.
NASDAQ:NBTX
$1.80B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.09B
Savara Inc.
NASDAQ:SVRA
$1.08B
Kura Oncology, Inc.
NASDAQ:KURA
$803.41M
Geron Corporation
NASDAQ:GERN
$737.75M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$722.58M
Prime Medicine, Inc.
NASDAQ:PRME
$501.21M
Rezolute, Inc.
NASDAQ:RZLT
$385.17M
ProKidney Corp.
NASDAQ:PROK
$242.99M
What is the latest TYRA filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does TYRA have?
Intrinsic Alpha currently shows 20 recent filings for TYRA.
Explore More
Continue the stock analysis
Jump to another research area for this company.